BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 12500397)

  • 21. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein.
    Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL
    Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibitive effects of recombinant adenovirus-mediated human endostatin on the growth of human hepatocellular carcinoma xenograft in nude mice].
    Li L; Wu PH; Huang JL; Liu RY; Zeng YX; Huang WL
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):542-5. PubMed ID: 14552715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.
    Kisker O; Becker CM; Prox D; Fannon M; D'Amato R; Flynn E; Fogler WE; Sim BK; Allred EN; Pirie-Shepherd SR; Folkman J
    Cancer Res; 2001 Oct; 61(20):7669-74. PubMed ID: 11606410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vasoinhibitory effect of daltepartin sodium on human hepatocellular carcinoma in nude mice].
    Yan J; Zheng Q; Wang Y; Lu HF; Xue Q; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):359-61. PubMed ID: 15918971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium.
    Solaun MS; Mendoza L; De Luca M; Gutierrez V; López MP; Olaso E; Lee Sim BK; Vidal-Vanaclocha F
    Hepatology; 2002 May; 35(5):1104-16. PubMed ID: 11981760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination.
    Yu HK; Ahn JH; Lee HJ; Lee SK; Hong SW; Yoon Y; Kim JS
    J Gene Med; 2005 Jan; 7(1):39-49. PubMed ID: 15517541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunochemotherapy prevents human colon cancer metastasis after orthotopic onplantation of histologically-intact tumor tissue in nude mice.
    Furukawa T; Kubota T; Watanabe M; Kuo TH; Kase S; Saikawa Y; Tanino H; Teramoto T; Ishibiki K; Kitajima M
    Anticancer Res; 1993; 13(2):287-91. PubMed ID: 8517641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095).
    Radulovic S; Miller G; Schally AV
    Cancer Res; 1991 Nov; 51(21):6006-9. PubMed ID: 1682040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].
    Wu Y; Yang L; Zhao X; Su JM; Hu B; Liu JY; Niu T; Luo Y; Li Q; Wei YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):557-61. PubMed ID: 15583981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporation.
    Uesato M; Gunji Y; Tomonaga T; Miyazaki S; Shiratori T; Matsubara H; Kouzu T; Shimada H; Nomura F; Ochiai T
    Cancer Gene Ther; 2004 Sep; 11(9):625-32. PubMed ID: 15338011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
    Plonowski A; Schally AV; Nagy A; Sun B; Szepeshazi K
    Cancer Res; 1999 Apr; 59(8):1947-53. PubMed ID: 10213505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors.
    Capillo M; Mancuso P; Gobbi A; Monestiroli S; Pruneri G; Dell'Agnola C; Martinelli G; Shultz L; Bertolini F
    Clin Cancer Res; 2003 Jan; 9(1):377-82. PubMed ID: 12538491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy.
    Joki T; Machluf M; Atala A; Zhu J; Seyfried NT; Dunn IF; Abe T; Carroll RS; Black PM
    Nat Biotechnol; 2001 Jan; 19(1):35-9. PubMed ID: 11135549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model.
    te Velde EA; Vogten JM; Gebbink MF; van Gorp JM; Voest EE; Borel Rinkes IH
    Br J Surg; 2002 Oct; 89(10):1302-9. PubMed ID: 12296902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
    Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
    Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
    Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
    Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice.
    Wang X; Fu X; Brown PD; Crimmin MJ; Hoffman RM
    Cancer Res; 1994 Sep; 54(17):4726-8. PubMed ID: 8062271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and limits of an orthotopic human colon cancer model in nude mice.
    Thalheimer A; Illert B; Bueter M; Gattenlohner S; Stehle D; Gasser M; Thiede A; Waaga-Gasser AM; Meyer D
    Comp Med; 2006 Apr; 56(2):105-9. PubMed ID: 16639976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
    Beck MT; Chen NY; Franek KJ; Chen WY
    Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.